Copying biotech medicine attracts more drugmakers

* Merck has Neupogen, Neulasta biosimilar trials underway
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.